IRM vs ZYME · P/E 136, rev $6.15B vs rev $76.3M
Iron Mountain Incorporated (IRM) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
IRM currently screens at market cap $37.09B and trailing P/E 135.5. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the IRM and ZYME stock pages for the full models.
Not investment advice.